Chronic fatigue syndrome
Overview
ME/CFS is a neuroimmune condition characterised by profound fatigue not explained by other causes, significantly worsened by exertion. NICE 2021 (NG206) removed graded exercise therapy and repositioned CBT.
Presentation
All five core features must be present for diagnosis (symptoms ≥4 months in adults, ≥3 months in children/young people):
•Debilitating fatigue - worse after activity, not primarily from exertion, not relieved by rest
•Post-exertional malaise (PEM) - worsening of ALL symptoms (physical, cognitive, immune) delayed 12-48 hours after exertion, lasting days to weeks
•Unrefreshing sleep - waking unrestored; insomnia or hypersomnia
•Cognitive impairment - 'brain fog'; memory, concentration, word-finding, processing speed
•Orthostatic intolerance - lightheadedness, palpitations, worsening on standing; may meet PoTS criteria
Investigations
No diagnostic test exists - investigations exclude treatable organic causes before confirming diagnosis.
🥇 First-line
•FBC, TFTs (TSH), fasting glucose/HbA1c, ESR, CRP, U&Es, LFTs, calcium, urinalysis
🥈 Second-line
•coeliac screen (anti-TTG IgA), active B12/folate if macrocytosis, sleep study if OSA suspected
Management
🥇 First-line
•Energy management/pacing - identify individual energy envelope and stay within it; delivered by occupational therapist with ME/CFS expertise
•Supported self-management - information, validated resources, regular review
•MDT referral to specialist ME/CFS service
🥈 Second-line
•CBT - offered only to support coping with chronic illness, comorbid anxiety/depression, or sleep difficulties; NOT a treatment for ME/CFS itself
•Symptomatic pharmacological management:
•Sleep disturbance - low-dose amitriptyline or melatonin
•Pain - NSAIDs or paracetamol
•Orthostatic intolerance/PoTS - fludrocortisone or propranolol under specialist guidance; increased fluid and salt intake, compression stockings, head-of-bed elevation
Follow-up
•Review every 3-6 months in stable patients; more frequently if newly diagnosed, deteriorating, or severely affected
•Reassess for organic pathology if presentation changes significantly or new symptoms emerge
•Assess for depression and anxiety as comorbidities at each review
Prognosis
•Full recovery possible, particularly in children/young people and milder/shorter illness
•Many adults have prolonged or fluctuating course; significant minority remain severely disabled long-term
•Better outcomes associated with early diagnosis, appropriate energy management, and avoidance of GET